NYSE:ABBV - New York Stock Exchange, Inc. - US00287Y1091 - Common Stock - Currency: USD
Taking everything into account, ABBV scores 5 out of 10 in our fundamental rating. ABBV was compared to 560 industry peers in the Biotechnology industry. ABBV has an excellent profitability rating, but there are concerns on its financial health. ABBV scores decently on growth, while it is valued quite cheap. This could make an interesting combination. ABBV also has an excellent dividend rating.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.05% | ||
ROE | 292.61% | ||
ROIC | 13.43% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 30.43% | ||
PM (TTM) | 7.24% | ||
GM | 70.69% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 46.56 | ||
Debt/FCF | 4.54 | ||
Altman-Z | 2.18 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.76 | ||
Quick Ratio | 0.64 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.74 | ||
Fwd PE | 13.47 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 22.1 | ||
EV/EBITDA | 15.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.36% |
192.45
-2.55 (-1.31%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 3.36% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 18.74 | ||
Fwd PE | 13.47 | ||
P/S | 5.93 | ||
P/FCF | 22.1 | ||
P/OCF | 20.73 | ||
P/B | 239.4 | ||
P/tB | N/A | ||
EV/EBITDA | 15.62 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 3.05% | ||
ROE | 292.61% | ||
ROCE | 17.5% | ||
ROIC | 13.43% | ||
ROICexc | 14.15% | ||
ROICexgc | 565.94% | ||
OM | 30.43% | ||
PM (TTM) | 7.24% | ||
GM | 70.69% | ||
FCFM | 26.82% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 46.56 | ||
Debt/FCF | 4.54 | ||
Debt/EBITDA | 2.56 | ||
Cap/Depr | 12.17% | ||
Cap/Sales | 1.77% | ||
Interest Coverage | 250 | ||
Cash Conversion | 63.55% | ||
Profit Quality | 370.28% | ||
Current Ratio | 0.76 | ||
Quick Ratio | 0.64 | ||
Altman-Z | 2.18 |